AzTrials
AzTrials

Osseointegration Failure of Dental ImplantDental ImplantNCT06967649

Prospective Longitudinal Clinical Study for the Evaluation of Peri-implant Tissue and Osseointegration After Rehabilitation With Osseointegrated Implants

A study testing TITANIUM IMPLANT in people with Osseointegration Failure of Dental Implant and Periimplantitis, run by Universidade Federal Fluminense at 1 site in Brazil.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The success of rehabilitation with osseointegrated implants is associated with numerous factors, including patient characteristics, installed implants, proper planning, and the prosthetic connections used. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
TITANIUM IMPLANT
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
350 participants
Where
1 siteBrazil
Study dates
4 Nov 2022to Feb 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Inclusion Criteria: Completion of surgical-prosthetic planning by the Implant Dentistry Clinic team at UFF, including osseointegrated implants and prosthetic components manufactured by SIN Implant System (São Paulo, Brazil); agreement to sign the informed consent form and willingness to be monitored for a period of 5 years, following the previously established course clinic protocol; systemically healthy patients who do not use antiresorptive and antiangiogenic drugs; patients with a plaque index <20% (Ainamo \& Bay 1975) and bleeding on probing <20% (Muhlemann \& Son 1971) at the start of the study.

-

Exclusion Criteria: Patients undergoing rehabilitation with implants from different systems and/or not performed at the UFF Implant Dentistry specialization clinic; patients unable to attend radiographic follow-up over 5 years; patients unable to respond to questions in clinical analysis and satisfaction survey forms; presence of systemic conditions preventing the surgical procedure for dental implant installation; presence of metabolic bone disorders; presence of untreated or uncontrolled chronic or aggressive periodontitis; pregnant or lactating women.

-

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Brazil1 site
  • Universidade Federal Fluminense

    Niterói, Rio de Janeiro, 24020140

Other trials in Brazil

About this study

The success of rehabilitation with osseointegrated implants is associated with numerous factors, including patient characteristics, installed implants, proper planning, and the prosthetic connections used. In the long term, success is closely related to the clinical radiographic follow-up of the implanted region and the identification of intrinsic or extrinsic factors that may interfere with implant survival. Therefore, the objective of this study is to evaluate, through clinical and radiographic analysis, the peri-implant tissues and prosthetic connections of research participants rehabilitated with osseointegrated implants at the Implant Dentistry Clinic of the Federal Fluminense University, over a period of 5 years. This will be a double-blind longitudinal study. A total of 148 research participants will be selected, respecting the inclusion criteria: completion of surgical-prosthetic planning by the Implant Dentistry Clinic team at UFF, including osseointegrated implants and prosthetic components manufactured by SIN Implant System (São Paulo, Brazil); agreeing to and signing the informed consent form, being willing to be monitored for a period of 5 years; systemically healthy patients who do not use antiresorptive and antiangiogenic drugs; patients with a plaque index <20% (Ainamo \& Bay 1975) and bleeding on probing <20% (Muhlemann \& Son 1971) at the start of the study. Participants will undergo clinical and radiographic analysis of peri-implant tissues and prosthetic connections at the following intervals: up to 7 days after implant installation (Time 0), at the time of prosthesis installation (Time 1), 6 months after prosthesis installation (Time 2), and 1 to 5 years after prosthesis installation (Times 3, 4, 5, 6, and 7, respectively). It is expected that this longitudinal study will lead to a better understanding of the factors influencing peri-implant bone loss and long-term success.

Read the detailed description

Selection of Research Participants Patients treated in the Implant Dentistry specialization course at FO-UFF, who undergo implant dentistry planning and receive rehabilitative treatment with endosseous implants, will be invited to participate in the research, provided they meet the inclusion criteria.

  • Inclusion Criteria: Completion of surgical-prosthetic planning by the Implant Dentistry Clinic team at UFF, including osseointegrated implants and prosthetic components manufactured by SIN Implant System (São Paulo, Brazil); agreement to sign the informed consent form and willingness to be monitored for a period of 5 years, following the previously established course clinic protocol; systemically healthy patients who do not use antiresorptive and antiangiogenic drugs; patients with a plaque index <20% (Ainamo \& Bay 1975) and bleeding on probing <20% (Muhlemann \& Son 1971) at the start of the study.
  • Exclusion Criteria: Patients undergoing rehabilitation with implants from different systems and/or not performed at the UFF Implant Dentistry specialization clinic; patients unable to attend radiographic follow-up over 5 years; patients unable to respond to questions in clinical analysis and satisfaction survey forms; presence of systemic conditions preventing the surgical procedure for dental implant installation; presence of metabolic bone disorders; presence of untreated or uncontrolled chronic or aggressive periodontitis; pregnant or lactating women.

Based on these criteria, a total of 148 research participants will be included and followed for 72 months (6 years).

Installation of Osseointegrated Implants Research participants will undergo clinical and prosthetic planning (reverse planning), including clinical-tomographic examinations and complementary tests, such as biochemical blood analysis and, when necessary, surgical risk assessment, according to the UFF Implant Dentistry specialization course protocol. The surgical technique, type of implant installed, and selected prosthetic components will follow the manufacturer's recommendations (SIN Implant System, São Paulo, Brazil), always considering treatment options for optimal patient rehabilitation.

1.1. Clinical Evaluation The clinical evaluation will include detailed anamnesis, assessment of participant satisfaction, peri-implant clinical examination, and evaluation of prosthetic connections over 5 years (Appendix 2). Clinical data will be updated throughout the study evaluations (Table 1) to analyze possible changes in satisfaction or peri-implant tissue condition.

Immediately after implant installation, primary stability will be assessed, with implants considered stable if inserted with a torque above 30 N/cm, without any mobility (Atsumi et al., 2007).

The peri-implant clinical examination will be performed on the mesial, distal, buccal, and lingual surfaces of each implant using a North Carolina periodontal probe (PCPUNC15-6) Hufriedy do Brasil. The following clinical parameters will be observed: spontaneous bleeding, mobility presence; plaque and calculus presence; keratinized tissue presence; peri-implant biotype; mucosal color changes; presence of swollen areas; implant thread exposure; percussion sensitivity; implant function duration; peri-implant probing depth; bleeding on probing and/or suppuration after gentle probing; percussion sound; bone loss presence beyond what is observed after bone remodeling, as well as anamnesis for health data collection (Appendix 2).

Implants will be considered successful if they have no clinical mobility, absence of clinical symptoms such as swelling, paresthesia, or pain, no damage to surrounding structures, no damage to implant or components, no peri-implant radiolucency, and minimal crest bone height loss, according to Albrektsson et al. (1994) and Misch et al. (2008).

1.2. Radiographic Evaluation The radiographic examination consists of digital periapical radiography using the Shick Elite Digital Indicator Cone radiographic positioner - Indusbello. The choice of this radiographic technique is based on literature data highlighting its advantages, such as reduced magnification and distortion, better resolution, and image detail. All radiographic images will be taken using the same X-ray machine by a single operator, different from the operator conducting the clinical analyses. During the radiographic imaging, participants will wear a lead apron and thyroid collar, in compliance with Federal Ordinance 453/98 (01/06/1998).

The radiographic examination will be performed on all research participants, along with clinical exams at the intervals described in Table 1.

Examiner Calibration:

For the radiographic evaluations, a dentist will be calibrated to measure the distance from the implant platform to the first point of contact between bone and implant on the mesial and distal surfaces, using tools such as zoom and digital measurement in a specific image software (ImageProPlus® - Media Cybernetics, Inc.401 N. Washington Street, Suite 350 - Rockville, MD 20850 - United States). After 24 hours, the measurements will be repeated to verify the consistency of results and obtain calibration correlation.

The radiographs will be digitized and evaluated using the image software (ImageProPlus®) for the following parameter: Height of the Marginal Peri-implant Bone Crest: linear measurement of the distance from the implant platform to the first point of contact between bone and implant on the mesial and distal surfaces.

Physiological bone loss will be characterized by considering normal bone loss of one millimeter during the first year after implant placement and 0.2 mm per subsequent year, in accordance with the osseointegration period. Thus, the total amount of bone loss will be calculated based on diagnostic radiography, compared to the clinical implant placement protocol. If total bone loss exceeds 1 mm and 0.2 mm per year, the region will be diagnosed with peri-implantitis (Roos et al., 1997).

1.3. Tomographic Evaluation The tomographic examination will be conducted in partnership with a radiology clinic to be defined, using cone beam computed tomography (CBCT).

According to Monje et al. 2019, measurement accuracy is influenced by defect size and image quality. Intraoral radiography provides a two-dimensional image of the peri-implant bone, describing mesial and distal bone sites; however, it may underestimate incipient lesions and intraosseous defects. Geometric distortions and anatomical overlaps may also occur. In cases where three-dimensional bone visualization is necessary, CBCT can be the alternative.

Participants diagnosed with pathological bone loss radiographically will undergo a tomographic examination at the peri-implant diseased site, aiming to obtain a three-dimensional anatomical image of the bone with its peri-implant defect, serving as a comparison and analysis for the treatment option to be offered.

1.4. Statistical Analysis Prisma GraphPad 6.0 software (GraphPad Software, La Jolla, CA, USA) will be used for all statistical analyses. The distribution type of numerical variables, including clinical data and radiographic measurements, will be assessed using the Shapiro-Wilk test. Student's t-tests or Mann-Whitney tests will be applied for normally or non-normally distributed data, respectively. Paired analyses will be conducted for characteristic comparisons with a significance level of 0.05% (p<0.05). Logistic regression will evaluate the correlation of analyzed factors over the years and the success of rehabilitation.

Being tested
TITANIUM IMPLANT
Keywords
PERI-IMPLANT HEALTH, Dental implant survival rate, DENTAL IMPLANT, prospective study, osseointegration
Medical subject headings
Peri-Implantitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TITANIUM IMPLANTDevice

    The surgical technique, type of implant installed, and selected prosthetic components will follow the manufacturer's recommendations (SIN Implant System, São Paulo, Brazil), always considering treatment options for optimal patient rehabilitation.

Study groups in NCT06967649
Study groupRoleWhat they receive
IMPLANT PLACEMENTActive comparatorResearch participants will undergo clinical and prosthetic planning (reverse planning), including clinical-tomographic examinations and complementary tests, such as biochemical blood analysis and, when necessary, surgical risk assessment, according to the UFF Implant Dentistry specialization course protocol. The surgical technique, type of implant installed, and selected prosthetic components will follow the manufacturer's recommendations (SIN Implant System, São Paulo, Brazil), always considering treatment options for optimal patient rehabilitation.
Receives: Device: TITANIUM IMPLANT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PRIMARY IMPLANT STABILITY

    Data on the clinical and radiographic characteristics of the different installed implants and the short-term stability of their prosthetic connections will be obtained. Over the years of evaluation, there may be better recognition of the factors influencing peri-implant bone loss and long-term success.

    Measured: From enrollment to the end of treatment at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2025
  2. Study start4 Nov 2022
  3. Primary completion4 Oct 2023
  4. Study completionFeb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
350 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06967649
Sponsor's protocol ID
DENTAL IMPLANTS EVALUATION
Acronym
Dental Implant
Status last verified
May 2025
First submitted
3 May 2025
Last updated
13 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing TITANIUM IMPLANT in people with Osseointegration Failure of Dental Implant and Periimplantitis, run by Universidade Federal Fluminense at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 13 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PRIMARY IMPLANT STABILITY (time frame: From enrollment to the end of treatment at 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in